Driving Innovation

Collaborations are included across a wide range of therapeutic areas, such as:

• Cardiovascular Intervention & Structural Heart Diseases
• ElectroPhysiology & Cardiac Rhythm Management
• Orthopedics & Soft Tissue Repair
• Aortic & Peripheral Vascular Diseases
• Neurovascular Intervention & Neuro-Modulation
• Surgical and Critical Care & Intelligent Surgical Robotics
• Endocrine Management & In Vitro Fertilization
• Urology & Gynecology & Respiratory & Gastroenterology
• Ophthalmology, ENT, Dental & Full Body Aesthetics
• In vitro Diagnostics & Medical Imaging
• Solid Tumor Treatment Technologies
• Sleep Disorder, Depression & Rehabilitation

If you are looking for strategic partners like MicroPort^®, please contact BD@microport.com for further discussion.

Miracle Point^® Incubator Plus is a collection of professional service platforms that provide one-stop solutions to incubate ideas and accelerate new product launches.

Established from MicroPort^®’s experience in building businesses, Miracle Point^® is centered around a standardized incubation model that is much akin to an assembly line to build new businesses. Each new project is taken through the process starting from a concept all the way to successful commercial launch and public market capitalization or acquisition. The Miracle Point^® model also incorporates “closed-loop” feedback that can use MicroPort^®’s know-how and experience to rapidly provide project-specific troubleshooting to ensure projects are on track to quickly achieve product certification, mass production, and commercial success.

Currently, Miracle Point^® is incubating more than 30 companies in different fields, such as neuromodulation, robotics, sports medicine, aesthetic treatments, assisted reproduction, ophthalmology, wearable devices, and rehabilitation devices. Several companies have gone through the Miracle Point^® process and entered the capital market, including:

• Endovastec™ listed on the SSE STAR Market in July 2019.
• MicroPort^® CardioFlow and MicroPort^® MedBot™ which have been listed on the main board of HKEX in February and November 2021, respectively.

Miracle Point^® aims to support global innovators in making their concepts into
commercial and clinical reality by exclusive access to MicroPort^®’s experience and resources.

We welcome anybody around the world to join us in our mission of promoting better and longer lives through innovation and entrepreneurial spirit. Please contact MiraclePoint@microport.com for further information.

In order to understand the patient's medical needs in a more detailed way, and to better understand the pain points, MicroPort^® has built a platform for collecting medical insights in the Collaborative Creative Center to facilitate communication between MicroPort^® and patients, doctors, and innovatively develop products that truly belong to patients and doctors.

As early as 2002, MicroPort^® foresaw that doctors are the important Power for innovation transformation. Through close cooperation of medical workers, we can continuously develop innovative projects for the development of medical devices. Since the founding of MicroPort^®, 48 medical cooperation projects have been developed, 9 of which have obtained CFDA certificates, and 8 of which have completed sample evaluation.

We are actively strengthening cooperation with the global medical industry to 'help people thrive beyond 115 years'. We hope to achieve a win-win situation after this close cooperation and to develop more useful products.